Science in Seconds | Researchers Discover New Bacterial Immune Systems
Scientists at Gladstone Institutes are developing new technologies for genome editing, which can correct mutations that cause disease. To build these technologies, they use parts from bacteria, including bacterial immune systems called retrons.
Seth Shipman and his team recently identified seven new retrons from environmental bacteria by sampling soil and water in nature. Their findings were published in the journal PLOS Biology.
In this video, the researchers explain how they co-opt the retrons’ ability to produce DNA inside cells and combine it with the CRISPR system to create better tools for genome editing, which can one day be used as therapeutics for a range of diseases.
Up Next
New CRISPR Screening Platform Boosts Power of Immunotherapy Against Solid Tumors
A new screening platform uncovers gene edits that enhance CAR-T cells’ ability to infiltrate and eliminate solid tumors.
New CRISPR Technique Selectively Shreds Cancer Cells, Including Those of ‘Undruggable’ Cancers
An innovative chromatin-shredding technique shown to destroy cancer cells carrying a prevalent mutation while keeping healthy cells intact.
Gladstone Launches Center for PhAIge Therapy to Harness AI in the Fight Against Drug-Resistant Infections
The center, funded by an NIH grant, will become one of three national centers dedicated to accelerating the development of phage therapy.
A Universal Toolkit for Editing Bacterial DNA
Scientists at Gladstone expanded their retron-based genome editing technology beyond E. coli, showing it works in 15 diverse bacterial species.
Get Involved
Join the Team
Our people are our most important asset. We offer a wide array of career opportunities both in our administrative offices and in our labs.
Open PositionsPartner With Us
Discoveries don’t stay in our labs. Gladstone facilitates spinout companies to advance promising therapies, shortening the path between scientific discovery and helping real patients.
Learn MoreGive
Your gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
Donate Now